APVO Aptevo: Nilai perusahaan marang volume dodolan

Simbol resmi perusahaan Aptevo (APVO)

The EV/Sales ratio on the GURU.Markets base chart demonstrates the valuation of Aptevo Therapeutics (APVO), whose ADAPT oncology ecosystem links pharma giants through long-term licenses. The development of ADAPTIR precision antibodies aims for the targeted destruction of tumors via T-cells. Meanwhile, 0.00 represents the current value of this metric, considering the FDA's influence on drug toxicity in AML treatment and the influx of R&D capital.

APVO (Aptevo) riwayat Multiplikator EV/Sales saka 23.11.2025 nganti 20.11.2026

APVO (Aptevo): rincian analitis lan laporan miturut indikator

- kuotasi saiki lan rata-rata prakiraan nilai:
Pambiji fundamental:Aptevo Therapeutics APVO
Barang unggulan Aptevo Therapeutics, Inc.

This metric measures the total enterprise value, including net debt, relative to a unit of revenue, allowing for an assessment of the asset's real value regardless of financial leverage. By analyzing the EV/Sales ratio, an investor can determine how the market currently prices in the potential of the Aptevo Therapeutics (APVO) bispecific antibody platform, accounting for the risks of its narrow clinical portfolio and the support of strategic partners.

Pesaing langsung

ARGX - Multiplikator EV/Sales|BNTX: Multiplikator EV/Sales|ABVX (Abivax SA) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ADMA Corp|Multiplikator nilai perusahaan marang pendapatan Protagonist Therapeutics PTGX|Nilai perusahaan marang pendapatan IMVT (Immunovant Therapeutics)|Rasio total nilai perusahaan marang pendapatan kiniksa.com|Rasio nilai perusahaan marang pendapatan Grifols Biemat GRFS|Koefisien nilai perusahaan marang pendapatan ADPT (Adaptive Biotechnologies Corporation)|celldex.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Aurinia Pharma AUPH|biocryst.com (BCRX) - Rasio nilai perusahaan marang pendapatan|Vera Therapeutics, Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Dianthus Therapeutics Inc|Pharvaris NV (PHVS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales ABCL|Tourmaline Corp - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales PGEN (precigen.com)|Rasio nilai perusahaan marang dodolan pharming.com|NKTR - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Upstream Bio Corp|ZBIO: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Immunome, Inc.|Nilai perusahaan marang pendapatan GOSS|KALV: Nilai bisnis marang pendapatan|Multiplikator EV/Sales SEPN|Nilai perusahaan marang pendapatan Pieris Pharmaceuticals, Inc. PVLA|Multiplikator EV/Sales SVRA (Savara Inc)|Multiplikator EV/Sales Rigel Pharmaceuticals RIGL|AnaptysBio Inc. - Multiplikator EV/Sales|Astria Therapeutics - Koefisien nilai perusahaan marang pendapatan|ENGN: Multiplikator EV/Sales|RAPT - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan JBIO|Aclaris (ACRS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales KYTX|Nilai perusahaan marang pendapatan Tiziana Life Sciences TLSA|Multiplikator EV/Sales CABA (cabalettabio.com)|Koefisien nilai perusahaan marang pendapatan VTYX (Ventyx Bio)|Theratechnologies, Inc - Multiplikator EV/Sales|AVTX (Avalo Therapeutics Inc.) - Rasio nilai perusahaan marang pendapatan|eledon.com (ELDN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan AGEN|CLYM (climbbio.com) - Multiplikator EV/Sales|Multiplikator EV/Sales zurabio.com|Rasio nilai perusahaan marang pendapatan aTyr (ATYR)|ADAG - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ImageneBio Inc IMA|Multiplikator EV/Sales Shattuck Labs, Inc. STTK|EQ - Rasio nilai perusahaan marang pendapatan|connectbiopharm.com (CNTB) - Nilai perusahaan marang pendapatan|IMUX (Immunic) - Nilai perusahaan marang pendapatan|Atara Biotherapeutics, Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan InflaRx|Nilai perusahaan marang pendapatan x4pharma.com (XFOR)|Multiplikator EV/Sales ACET|Nilai perusahaan marang pendapatan Celularity Corp CELU|INmune Bio Inc - Nilai perusahaan marang pendapatan|BRNS (Barinthus Bio) - Nilai perusahaan marang volume dodolan|KZR - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan sabbiotherapeutics.com SABS|Akari Therapeutics PLC (AKTX) - Rasio nilai perusahaan marang pendapatan|ENLV - Rasio total nilai perusahaan marang pendapatan|QTTB (Q32 Bio) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan GeoVax Labs Inc GOVX|Rasio nilai perusahaan marang pendapatan Edesa Biotech (EDSA)|Nilai perusahaan marang pendapatan iBio IBIO|Carisma Therapeutics Inc - Nilai perusahaan marang pendapatan|XTLB - Nilai perusahaan marang pendapatan|BOLT - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan HCWB (hcwbiologics.com)|AIM (AIM ImmunoTech, Inc.) - Nilai perusahaan marang pendapatan|Aditxt Corp - Nilai bisnis marang pendapatan|GRI (GRI Bio Inc) - Multiplikator EV/Sales|Multiplikator EV/Sales XORTX Therapeutics Inc|Rasio nilai perusahaan marang pendapatan Vyome Therapeutics (HIND)|REVB - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Indaptus Therapeutics, Inc. INDP|Multiplikator EV/Sales scinai.com SCNI|CalciMedica Inc - Multiplikator EV/Sales|AFMD - Multiplikator EV/Sales|ALLK: Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan HOOK (HOOKIPA Pharma, Inc.)|IGMS (IGM Biosciences) - Multiplikator EV/Sales|ITOS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan OCEA (Ocean Biomedical)|TCBP: Nilai perusahaan marang volume dodolan|Rasio nilai perusahaan marang pendapatan Third Harmonic Bio Inc THRD